TB-PACTS data platform Mission:
The TB-PACTS data platform is designed to catalyze and accelerate TB research by curating and standardizing Phase III tuberculosis (TB) clinical trial data and making this data publicly available to qualified researchers. Researches can access and analyze data in aggregate, or filter and view individual patient-level data from the REMoxTB, RIFAQUIN and OFLUTUB clinical trials. Additional trial data may be available in the future.
TB-PACTS data platform Partnership:
This initiative represents a collaborative partnership between the Special Progamme for Research and Training in Tropical Diseases (TDR), the TB Alliance, St. George’s University of London and Critical Path Institute (C-Path).
TB-PACTS data platform Content and Access:
The TB–PACTS data platform will catalogue contemporary (TB) clinical trial data sets and make these data sets available to qualified researchers. Approved researchers can access patient-level data from the REMoxTB, RIFAQUIN and OFLOTUB clinical trials. Additional trial data is expected to be made available in the future.
For information on how to access the TB-PACTS data platform, visit the TB-PACTS Platform page on this website.
For more information on TB-PACTS or how your organization can contribute data, please contact:
Executive Director , Critical Path to TB Drug Regimens